- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech
![No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech](https://medicaldialogues.in/h-upload/2020/06/20/750x450_130651-paracetamol.webp)
New Delhi: Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine Covaxin.
Stating that it has received feedback that certain immunisation centres are recommending taking three paracetamol 500mg tablets along with Covaxin for children, the company clarified that such a step was not required.
Also Read:Study shows Covaxin safe, immunogenic in 2-18 age group: Bharat Biotech
"No paracetamol or painkillers are recommended after being vaccinated with Covaxin," Bharat Biotech said in a tweet.
Paracetamol was recommended along with certain other COVID-19 vaccines and is not recommended for Covaxin, it asserted.
"Through our clinical trials spanning 30,000 individuals, approximately 10-20 per cent individuals report side effects. Most of these are mild, resolve within 1-2 days, and do not require medication. Medication is only recommended only after you consult a physician," the company said.
Last month, the Drugs Controller General of India (DCGI) had granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin for children above 12 years with certain conditions.
Prime Minister Narendra Modi had announced that vaccination against COVID-19 for children between 15-18 years would start from January 3.
Subsequently, India opened up vaccination for the 15-18 years age-group on Monday and so far over 85 lakh beneficiaries in the category have received the first shot.
Also Read:Bharat Biotech seeks DCGI nod for study of intra-nasal COVID vaccine as booster dose
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.